Rothschild Investment »

Inhibikase Therapeutics shares owned by Rothschild Investment

Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Rothschild Investment from 13F filings

Historical chart of Rothschild Investment investment in Inhibikase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Inhibikase Therapeutics held by Rothschild Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibikase Therapeutics by Rothschild Investment

Quarter filed Position value Share count Share price at filing
2026-06-30 $884 436 2.03
2026-03-31 $47 28 1.68

More positions owned by Rothschild Investment

Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Jpmorgan Chase & Co Stock (JPM)
Amazon Stock (AMZN)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Microsoft Corp Stock (MSFT)
Invesco Rafi Us 1000 Etf Etf (PRF)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Palo Alto Networks Stock (PANW)
Abbvie Stock (ABBV)
Blackstone Stock (BX)
Costco Wholesale Corporation Stock (COST)
Avantis U.s. Small Cap Value Etf Etf (AVUV)
Capital Group Dividend Growers Etf Etf (CGDG)

View all positions for Rothschild Investment

Top funds holding Inhibikase Therapeutics

Sands Capital Ventures
Soleus Capital Management
Trails Edge Capital Partners
Fairmount Funds Management
BlackRock
ADAR1 Capital Management
Blackstone Group
Siren
Commodore Capital
Vanguard Capital Management
Millennium Management
Saturn V Capital Management
Kalehua Capital Management
Spruce Street Capital
Squadron Capital Management

View all funds holding Inhibikase Therapeutics